Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia

Affiliations

¹ Group for Biomedical Research in Sepsis (Bio Sepsis), Hospital Clínico Universitario de Valladolid /IECSCYL, 47003 Valladolid, Spain. Electronic address: jfbermejo@saludcastillayleon.es.
² Group for Biomedical Research in Sepsis (Bio Sepsis), Hospital Clínico Universitario de Valladolid /IECSCYL, 47003 Valladolid, Spain.
³ Pulmonology Service, University and Polytechnic Hospital La Fe, Ciber de Enfermedades Respiratorias (Ciberes), València, Spain.
⁴ Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona-SGR 911- Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.

Jesus F Bermejo-Martin et al. Lancet Respir Med. 2017 Dec.

. 2017 Dec;5(12):e35-e36.

doi: 10.1016/S2213-2600(17)30444-7.

¹ Group for Biomedical Research in Sepsis (Bio Sepsis), Hospital Clínico Universitario de Valladolid /IECSCYL, 47003 Valladolid, Spain. Electronic address: jfbermejo@saludcastillayleon.es.
² Group for Biomedical Research in Sepsis (Bio Sepsis), Hospital Clínico Universitario de Valladolid /IECSCYL, 47003 Valladolid, Spain.
³ Pulmonology Service, University and Polytechnic Hospital La Fe, Ciber de Enfermedades Respiratorias (Ciberes), València, Spain.
⁴ Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona-SGR 911- Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.

No abstract available

Publication types